Skip to main content
SpringerLink
Log in

Cerebellar Syndrome Associated with Thyroid Disorders

  • Review
  • Published:
The Cerebellum Aims and scope Submit manuscript

Abstract

Thyroid disorders, including hypothyroidism, hyperthyroidism and Hashimoto encephalopathy, are considered the most common cause of cerebellar dysfunction due to hormonal imbalance. Typically, cerebellar impairment occurs in the course of hypothyroidism and Hashimoto encephalopathy. Information about demographic, clinical and laboratory features of cerebellar disease associated with thyroid disorders is poor. Our review of the literature (1965 to 2018) identified 28 cases associated with hypothyroidism and 37 cases associated with Hashimoto encephalitis. Both patients with hypothyroidism and Hashimoto encephalopathy presented with signs of ataxia that were similarly distributed in the two groups and were mostly predictive of vermis involvement and frequent impairment of cerebellar hemispheres. Additional neurological signs, like dystonia, psychiatric symptoms, ocular disturbances and myoclonus, could be found in the Hashimoto encephalopathy group alone. When present, atrophy of vermis and often of both cerebellar hemispheres was the main imaging abnormality in both hypothyroidism and Hashimoto encephalopathy. Anti-thyroid antibodies could be detected in three quarters of patients with hypothyroidism and in all patients with Hashimoto encephalopathy. In the patients with hypothyroidism, thyroid replacement therapy yielded complete or partial remission of ataxia. In the Hashimoto encephalopathy group, immunosuppressive treatment provided complete remission of ataxia in about 60% of patients, partial remission in the remaining cases. Owing to the treatable nature of the condition and the high prevalence of thyroid disease among general population, cerebellar syndrome associated with thyroid disorders should be considered an important clinical entity. Information from this review will hopefully stimulate and strengthen awareness of thyroid-associated ataxia among clinicians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Manto M, Hampe CS. Endocrine disorders and the cerebellum: from neurodevelopmental injury to late-onset ataxia. In: Manto M, Huisman TAGM, editors. Handbook of Clinical Neurology, vol. 155 (3rd series) The Cerebellum: Disorders and Treatment. Elsevier; 2018.

    Chapter  Google Scholar 

  2. Manto M. Endocrine disorders. In: Manto M, Gruol DL, Schmahmann JD, Koibuchi N, Rossi F, editors. Handbook of the Cerebellum and Cerebellar Disorders. Springer; 2013.

  3. Jellinek EH, Kelly RE. Cerebellar syndrome in myxoedema. Lancet. 1960;2(7144):225–7.

    Article  CAS  PubMed  Google Scholar 

  4. Kotwal SK, Kotwal S, Gupta R, Singh JB, Mahajan A. Cerebellar ataxia as presenting feature of hypothyroidism. Arch Endocrinol Metab. 2016;60(2):183–5.

    Article  PubMed  Google Scholar 

  5. Hammar CH, Regli F. Cerebellar ataxia due to hypothyroidism in adults (case report). Dtsch Med Wochenschr. 1975;100(28):1504–6.

    Article  CAS  PubMed  Google Scholar 

  6. Edvardsson B, Persson S. Subclinical hypothyroidism presenting with gait abnormality. Neurologist. 2010;16(2):115–6.

    Article  PubMed  Google Scholar 

  7. Pinelli P, Pisano F, Miscio G. Ataxia in myxoedema: a neurophysiological reassessment. J Neurol. 1990;237(7):405–9.

    Article  CAS  PubMed  Google Scholar 

  8. Hannan MA, Sarker I, Fariduddin M, Begum A, Hossain S, Sultana N. Recurrent cerebellar ataxia in a young lady with Hashimoto’s thyroiditis. Am J Med Case Rep. 2016;4(6):204–7.

    Google Scholar 

  9. Raj BP, Anand R, Harikrishnan BL. Cerebellar ataxia as the presenting feature of hypothyroidism. Kerala Med J. 2016;9(4):172–3.

    Google Scholar 

  10. Gentilini M, Palmieri M. Myxedematous cerebellar ataxia. Description of a case. Riv Patol Nerv Ment. 1984;105(2):75–80.

    CAS  PubMed  Google Scholar 

  11. Caffarra P, Malvezzi L, Valenti G. Ataxia and hypothyroidism. Ital J Neurol Sci. 1986;7(6):625.

    Article  CAS  PubMed  Google Scholar 

  12. Badran A, Moran C, Coles A. Hypothyroid ataxia complicating monoclonal antibody therapy. Pract Neurol. 2017;17(6):482–4.

    Article  PubMed  Google Scholar 

  13. Ashworth B. Ataxia and hypothyroidism. Bristol Med Chir J. 1965;80(1):1–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Sinharay R. Hypothyroidism mimicking intra-abdominal malignancy. BMJ. 2002;325:946.

    Article  Google Scholar 

  15. Sangle SA, Lohiya RV, Sharma DR, Bote N. Hypothyroidism—gait matters. J Postgrad Med. 2012;58:159.

    Article  CAS  PubMed  Google Scholar 

  16. Barnard RO, Campbell MJ, McDonald WI. Pathological findings in a case of hypothyroidism with ataxia. J Neurol Neurosurg Psychiatry. 1971;34(6):755–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Rao RS, Sheshadri S, Bhattacharjee D, Patil N, Rao K. Progressive non-familial adult onset cerebellar degeneration: an unusual occurrence with Hashimoto’s thyroiditis. Psychopharmacol Bull. 2018;48(3):42–6.

    PubMed  PubMed Central  Google Scholar 

  18. Pavan MR, Deepak M, Besavaprabhu A, Gupta A. Doctor I am swaying: an interesting case of ataxia. J Clin Diagn Res. 2012;6(4):702–3.

    Google Scholar 

  19. Berris B, Owen T. Unusual manifestations of myxedema. Can Med Assoc J. 1965;3(93):21–5.

    Google Scholar 

  20. Westphal SA. Unusual presentations of hypothyroidism. Am J Med Sci. 1997;314(5):333–7.

    CAS  PubMed  Google Scholar 

  21. Selim M, Drachman D. Ataxia associated with Hashimoto’s disease: progressive non-familial adult onset cerebellar degeneration with autoimmune thyroiditis. J Neurol Neurosurg Psychiatry. 2001;71(1):81–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Álvarez BG, Yusta IA, Carvalho MG, Sánchez I. Cerebellopathy secondary to anti-peroxidase antibody-mediated toxicity. A special case of Hashimoto encephalopathy. J Neuroimmunol. 2017;15(312):1–3.

    Article  CAS  Google Scholar 

  23. Alzuabi MA, Saad AM, Al-Husseini MJ, Nada MA. An unusual cause of cerebellovestibular symptoms. BMJ Case Rep. 2016;13:2016.

    Google Scholar 

  24. Lee HJ, Jeon K, Lee JY, Lee JE, Bae DW, Oh YS, et al. Ocular flutter and ataxia without cognitive impairment associated with steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT). J Neurol Sci. 2015;359(1–2):86–7.

    Article  PubMed  Google Scholar 

  25. Matsunaga A, Ikawa M, Fujii A, Nakamoto Y, Kuriyama M, Yoneda M. Hashimoto's encephalopathy as a treatable adult-onset cerebellar ataxia mimicking spinocerebellar degeneration. Eur Neurol 2013; 69(1):14–20.

    Article  Google Scholar 

  26. Nakagawa H, Yoneda M, Fujii A, Kinomoto K, Kuriyama M. Hashimoto’s encephalopathy presenting with progressive cerebellar ataxia. J Neurol Neurosurg Psychiatry. 2007;78:19–7.

    Article  Google Scholar 

  27. Manto M, Goldman S, Bodur H. Cerebellar syndrome associated with Hashimoto’s encephalopathy. Rev Neurol (Paris). 1996;152(3):202–4.

    CAS  Google Scholar 

  28. Yamamoto M, Wada-Isoe K, Yoneda M, Doi K, Kowa H, Nakashima K. A case of acute cerebellar ataxia associated with serum anti-NH2 terminal of alpha-enolase (NAE) antibody. Rinsho Shinkeigaku. 2010;50:581–4.

    Article  PubMed  Google Scholar 

  29. Tang Y, Chu C, Lin MT, Wei G, Zhang X, Da Y, et al. Hashimoto’s encephalopathy mimicking spinocerebellar ataxia. J Neurol. 2011;258:1705–7.

    Article  PubMed  Google Scholar 

  30. Tran MH, Mkhikian H, Sy M, Perez-Alvarez I, Demetriou M. Long-term plasma exchange as maintenance therapy for cerebellar-type Hashimoto’s encephalopathy, a case report. Transfus Apher Sci. 2018;57(3):418–20.

    Article  PubMed  Google Scholar 

  31. Yoneda M. Ataxic form of Hashimoto’s encephalopathy. Rinsho Shinkeigaku. 2012;52(11):1369–71.

    Article  PubMed  Google Scholar 

  32. Termsarasab P, Pitakpatapee Y, Frucht SJ, Srivanitchapoom P. Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT) presenting with pure cerebellar ataxia. Tremor Other Hyperkinet Mov. 2018;8:585.

    Google Scholar 

  33. Avila A, Serrado A, Reig L, Famades A, Maho P. Early presentation of gait disturbance in a steroid-responsive encephalopathy associated with autoimmune thyroiditis. Eur J Neurol. 2013;10(5):601.

    Article  Google Scholar 

  34. Montagna G, Imperiali M, Agazzi P, D'Aurizio F, Tozzoli R, Feldt-Rasmussen U, et al. Hashimoto’s encephalopathy: a rare proteiform disorder. Autoimmun Rev. 2016;15(5):466–76.

    Article  PubMed  Google Scholar 

  35. Bodranghien F, Bastian A, Casali C, Hallett M, Louis ED, Manto M, et al. Consensus paper: revisiting the symptoms and signs of cerebellar syndrome. Cerebellum. 2016;15(3):369–91.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Timmann D, Brandauer B, Hermsdörfer J, Ilg W, Konczak J, Gerwig M, et al. Lesion-symptom mapping of the human cerebellum. Cerebellum. 2008;7(4):602–6.

    Article  CAS  PubMed  Google Scholar 

  37. Klockgether T. Sporadic ataxia with adult onset: classification and diagnostic criteria. Lancet Neurol. 2010;9(1):94–104.

    Article  CAS  PubMed  Google Scholar 

  38. Subramony SH. Overview of autosomal dominant ataxias. In: Subramony SH and Durr A, editors. Handb Clin Neurol, vol 103 (3rd series), Ataxic disorders. 2012;103:389–98.

  39. Antenora A, Rinaldi C, Roca A, Pane C, Lieto M, Saccà F, et al. The multiple faces of spinocerebellar ataxia type 2. Ann Clin Transl Neurol. 2017;4(9):687–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Geschwind DH, Perlman S, Figueroa CP, Treiman LJ, Pulst SM. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet. 1997;60(4):842–50.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Velázquez-Pérez LC, Rodríguez-Labrada R, Fernandez-Ruiz J. Spinocerebellar ataxia type 2: clinicogenetic aspects, mechanistic insights, and management approaches. Front Neurol. 2017;8:472.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Tang B, Liu C, Shen L, Dai H, Pan Q, Jing L, et al. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds. Arch Neurol. 2000;57(4):540–4.

    Article  CAS  PubMed  Google Scholar 

  43. Jardim LB, Pereira ML, Silveira I, Ferro A, Sequeiros J, Giugliani R. Neurologic findings in Machado-Joseph disease: relation with disease duration, subtypes, and (CAG)n. Arch Neurol. 2001;58(6):899–904.

    Article  CAS  PubMed  Google Scholar 

  44. Paulson H. Machado-Joseph disease/spinocerebellar ataxia type 3. Overview of autosomal dominant ataxias. In: Subramony SH and Durr A, editors. Handb Clin Neurol, Vol 103 (3rd series), Ataxic disorders. 2012;103:437–449.

  45. Galvin R, Bråthen G, Ivashynka A, Hillbom M, Tanasescu R, Leone MA. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010;17(12):1408–18.

    Article  CAS  PubMed  Google Scholar 

  46. Monti G, Pugnaghi M, Ariatti A, Mirandola L, Giovannini G, Scacchetti S, et al. Non-convulsive status epilepticus of frontal origin as the first manifestation of Hashimoto’s encephalopathy. Epileptic Disord. 2011;13(3):253–8.

    PubMed  Google Scholar 

  47. Bektas Ö, Yılmaz A, Kendirli T, Sıklar Z, Deda G. Hashimoto encephalopathy causing drug-resistant status epilepticus treated with plasmapheresis. Pediatr Neurol. 2012;46(2):132–5.

    Article  PubMed  Google Scholar 

  48. Striano P, Pagliuca M, Andreone V, Zara F, Coppola A, Striano S. Unfavourable outcome of Hashimoto encephalopathy due to status epilepticus. One autopsy case. J Neurol. 2006;253(2):248–9.

    Article  CAS  PubMed  Google Scholar 

  49. Ferlazzo E, Raffaele M, Mazzù I, Pisani F. Recurrent status epilepticus as the main feature of Hashimoto’s encephalopathy. Epilepsy Behav. 2006;8(1):328–30.

    Article  PubMed  Google Scholar 

  50. Cantón A, de Fàbregas O, Tintoré M, Mesa J, Codina A, Simó R. Encephalopathy associated to autoimmune thyroid disease: a more appropriate term for an underestimated condition? J Neurol Sci. 2000;176(1):65–9.

    Article  PubMed  Google Scholar 

  51. Al-Busaidi M, Burad J, Al-Belushi A, Gujjar A. Super refractory status epilepticus in Hashimoto’s encephalopathy. Oman Med J. 2017;32(3):247–50.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Chaigne B, Mercier E, Garot D, Legras A, Dequin PF, Perrotin D. Hashimoto’s encephalopathy in the intensive care unit. Neurocrit Care. 2013;18(3):386–90.

    Article  CAS  PubMed  Google Scholar 

  53. Hilberath JM, Schmidt H, Wolf GK. Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): case report of reversible coma and status epilepticus in an adolescent patient and review of the literature. Eur J Pediatr. 2014;173(10):1263–73.

    Article  PubMed  Google Scholar 

  54. Visée H, Mabiglia C, Vanderaspoilden V, Gazagnes MD, Glibert G. Recurrent status epilepticus associated with Hashimoto’s encephalopathy. Epilepsy Behav Case Rep. 2013;1:113–7.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Graham BR, Shiff N, Nour M, Hasal S, Huntsman R, Almubarak S. Hashimoto encephalopathy presenting with stroke-like episodes in an adolescent female: a case report and literature review. Pediatr Neurol. 2016;59:62–70.

    Article  PubMed  Google Scholar 

  56. Pari E, Rinaldi F, Premi E, Codella M, Rao R, Paghera B, et al. A follow-up 18F-FDG brain PET study in a case of Hashimoto’s encephalopathy causing drug-resistant status epilepticus treated with plasmapheresis. J Neurol. 2014;261(4):663–7.

    Article  PubMed  Google Scholar 

  57. Ercoli T, Defazio G, Muroni A. Status epilepticus in Hashimoto’s encephalopathy. Seizure. 2019;70:1–5.

    Article  PubMed  Google Scholar 

  58. Varrasi C, Vecchio D, Magistrelli L, Strigaro G, Tassi L, Cantello R. Auditory seizures in autoimmune epilepsy: a case with anti-thyroid antibodies. Epileptic Disord. 2017;19(1):99–103.

    PubMed  Google Scholar 

  59. Ghika-Schmid F, Ghika J, Regli F, Dworak N, Bogousslavsky J, Stadler C, et al. Hashimoto’s myoclonic encephalopathy: an underdiagnosed treatable condition? Mov Disord. 1996;11:555–62.

    Article  CAS  PubMed  Google Scholar 

  60. Marshall GA, Doyle JJ. Long-term treatment of Hashimoto’s encephalopathy. J Neuropsychiatr Clin Neurosci. 2006;18:14–20.

    Article  Google Scholar 

  61. Yu H, Lee J, Seo D, Lee M. Clinical manifestations and treatment response of steroid in pediatric Hashimoto encephalopathy. J Child Neurol. 2014;29:938–42.

    Article  PubMed  Google Scholar 

  62. Gul Mert G, Horoz OO, Herguner MO, Incecik F, Yildizdas RD, Onenli Mungan N, et al. Hashimoto’s encephalopathy: four cases and review of literature. Int J Neurosci. 2014;124:302–6.

    Article  PubMed  Google Scholar 

  63. Hommet C, Mondon K, Huc M, Jeffredo S, Constans T, de Toffol B, et al. Atypical neuropsychiatric symptoms revealing Hashimoto’s encephalopathy. J Am Geriatr Soc. 2007;55(7):1144–6.

    Article  PubMed  Google Scholar 

  64. Anand KS, Garg J, Verma R, Chakraborty A. Hashimoto’s encephalitis: unusual cause of reversible dementia. J Family Med Prim Care. 2014;3(3):284–6.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Mamoudjy N, Korff C, Maurey H, Blanchard G, Steshenko D, Loiseau-Corvez MN, et al. Hashimoto’s encephalopathy: identification and long-term outcome in children. Eur J Paediatr Neurol. 2013;17(3):280–7.

    Article  PubMed  Google Scholar 

  66. Mancardi MM, Fazzini F, Rossi A, Gaggero R. Hashimoto’s encephalopathy with selective involvement of the nucleus accumbens: a case report. Neuropediatrics. 2005;36(3):218–20.

    Article  CAS  PubMed  Google Scholar 

  67. Cummings RR, Bagley SC, Syed S, Dong N, Lin A. Hashimoto’s encephalopathy: a case report with neuropsychological testing. Gen Hosp Psychiatry. 2007;29(3):267–9.

    Article  PubMed  Google Scholar 

  68. Salpietro V, Mankad K, Polizzi A, Sugawara Y, Granata F, David E, et al. Pediatric Hashimoto’s encephalopathy with peripheral nervous system involvement. Pediatr Int. 2014;56:413–6.

    Article  PubMed  Google Scholar 

  69. Berger I, Castiel Y, Dor T. Paediatric Hashimoto encephalopathy, refractory epilepsy and immunoglobulin treatment unusual case report and review of the literature. Acta Paediatr. 2010;99:1903–5.

    Article  CAS  PubMed  Google Scholar 

  70. Shah SD, Murali H. Steroid-responsive encephalopathy and autoimmune thyroiditis in a young boy. Pediatr Neurol. 2011;45:132–4.

    Article  PubMed  Google Scholar 

  71. Huang X, Yu Y, Zhang H, Liu J, Sun Y, Chang M, et al. Hashimoto encephalopathy associated with hyperthyroidism: a case report. Exp Ther Med. 2014;8(2):515–8.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Carlone C, Todini L, Marini I, Majorana M, Casciato S, Giallonardo AT, et al. Acute psychiatric presentation of steroid-responsive encephalopathy: the under recognized side of autoimmune thyroiditis. Riv Psichiatr. 2013;48(2):169–73.

    PubMed  Google Scholar 

  73. Ishitobi M, Yoneda M, Ikawa M, Matsunaga A, Ueno K, Kimura H, et al. Hashimoto’s encephalopathy with hippocampus involvement detected on continuous arterial spin labeling. Psychiatry Clin Neurosci. 2013;67(2):128–9.

    Article  PubMed  Google Scholar 

  74. Cho BH, Cheon K, Lee KY. Hashimoto encephalopathy mimicking acute ischemic stroke: perfusion-weighted magnetic resonance imaging. J Clin Neurol. 2018;14(4):586–7.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Hernandez Echebarria LE, Saiz A, Graus F, Tejada J, Garcia JM, Clavera B, et al. Detection of 14-3-3 protein in the CSF of a patient with Hashimoto’s encephalopathy. Neurology. 2000;54:1539–40.

    Article  CAS  PubMed  Google Scholar 

  76. Cooper BL, Appel SE, Ammar HM. A young female with urinary retention-Hashimoto’s encephalopathy. Am J Emerg Med. 2017;35(6):943.

    Article  PubMed  Google Scholar 

  77. Kang WH, Na JY, Kim MK, Yoo BG. Hashimoto’s encephalopathy presenting with acute cognitive dysfunction and convulsion. J Epilepsy Res. 2013;3(2):70–3.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Dinkar K, Sinha S, Taly AB, Bindu PS, Bharath RD. Steroid-responsive encephalopathy in autoimmune thyroiditis: clinical spectrum and MRI observations in three cases. Ann Indian Acad Neurol. 2011;14(3):205–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Liu CY, Tseng MC, Lin PH. Encephalopathy associated with autoimmune thyroid disease (Hashimoto’s thyroiditis) presenting as depression: a case report. Gen Hosp Psychiatry. 2011;33(6):641.

    Article  PubMed  Google Scholar 

  80. Ghoreishi E, Shahidi GA, Rohani M, Nabavi M, Aghaei M, Akhoundi FH. Palatal-myoclonus as a presentation of Hashimoto encephalopathy: an interesting case report. Iran J Psychiatry. 2013;8(3):149–51.

    PubMed  PubMed Central  Google Scholar 

  81. Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW. Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab. 2009;94(6):1853–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Bjoro T, Holmen J, Krüger O, Midthjell K, Hunstad K, Schreiner T, et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol. 2000;143(5):639–47.

    Article  CAS  PubMed  Google Scholar 

  83. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–99.

    Article  CAS  PubMed  Google Scholar 

  84. Klockgether T. Sporadic adult-onset ataxia. In: Manto M and Huisman TAGM, editors. Handbook of Clinical Neurology, Vol. 155 (3rd series) The Cerebellum: Disorders and Treatment. Elsevier; 2018.

    Chapter  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Sciences and Public Health, Institute of Neurology, University of Cagliari and AOU Cagliari, 09042, Cagliari, Italy

    Tommaso Ercoli, Giovanni Defazio & Antonella Muroni

Authors
  1. Tommaso Ercoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giovanni Defazio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonella Muroni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tommaso Ercoli.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ercoli, T., Defazio, G. & Muroni, A. Cerebellar Syndrome Associated with Thyroid Disorders. Cerebellum 18, 932–940 (2019). https://doi.org/10.1007/s12311-019-01059-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12311-019-01059-9

Keywords

Search

Navigation